| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/31/2006 | CA2598279A1 Dosage and method for attaining beneficial levels of vitamin d3 |
| 08/31/2006 | CA2598226A1 Spheroids prepared from an isolated active principle of vegetable origin and a solution of vegetable origin containing the active principle or a precursor thereof |
| 08/31/2006 | CA2598210A1 Solid pharmaceutical composition comprising telithromycin |
| 08/31/2006 | CA2598031A1 Aqueous topical gel of high stability based on metronidazole and method of preparation |
| 08/31/2006 | CA2596965A1 Anti-misuse microparticulate oral drug form |
| 08/31/2006 | CA2594127A1 Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent |
| 08/31/2006 | CA2589479A1 Osmotic device containing amantadine and an osmotic salt |
| 08/31/2006 | CA2571982A1 Methods of modulating intracellular degradation rates of toxins |
| 08/30/2006 | EP1695991A1 Coordination complex of diaminocyclohexaneplatinum(ii) with block copolymer containing poly(carboxylic acid) segment and antitumor agent comprising the same |
| 08/30/2006 | EP1695729A1 Medicament delivery device comprising a flexible bag |
| 08/30/2006 | EP1695727A2 Transcutaneous delivery means |
| 08/30/2006 | EP1695718A2 Biodegradable polyester and Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 08/30/2006 | EP1695708A2 Pharmaceutical composition |
| 08/30/2006 | EP1695707A1 Nail varnish containing tazarotene and use thereof for treating and/or preventing psoriasis |
| 08/30/2006 | EP1695701A2 HFA suspension formulations comprising an anticholinergic agent |
| 08/30/2006 | EP1695700A1 Dosage form containing oxycodone and naloxone |
| 08/30/2006 | EP1695699A1 Drug-containing grains and solid preparation containing the grains |
| 08/30/2006 | EP1695698A1 Anti-angiogene compositions and methods of use |
| 08/30/2006 | EP1695697A1 Anti-angiogenic compositions and methods of use |
| 08/30/2006 | EP1695696A1 Liposome |
| 08/30/2006 | EP1695695A1 Water-in-oil type micro-emulsion |
| 08/30/2006 | EP1695691A2 Foaming composition for hair cleaning and hair treatment |
| 08/30/2006 | EP1695094A2 Disintegratable films for diagnostic devices |
| 08/30/2006 | EP1694400A1 Method and system for rapid transdermal administration |
| 08/30/2006 | EP1694370A1 Wound care products containing keratin |
| 08/30/2006 | EP1694344A1 Methods and composition for transplantation of dopaminergic neurons for parkinson s disease |
| 08/30/2006 | EP1694336A2 Oral solid instant-release dosage forms comprising finasteride and an anionic surfactant - methods of manufacturing thereof |
| 08/30/2006 | EP1694321A1 Tablets of citalopram hydrobromide |
| 08/30/2006 | EP1694320A1 Use of compositions comprising oleanic acid and ursolic acid for the preparation of a medicament for the treatment of hypersensitivity and hyperreactivity |
| 08/30/2006 | EP1694319A1 Use of 4-hydroxytamoxifen for the preparation of a medicament for the treatment of gynecomastia |
| 08/30/2006 | EP1694317A1 Copper antagonist compounds |
| 08/30/2006 | EP1694312A1 Iron salt coated with alginate and method for the preparation thereof |
| 08/30/2006 | EP1694311A2 Chewable soft capsules containing ungelatinized starch |
| 08/30/2006 | EP1694310A2 Modular imbibition rate reducer for use with implantable osmotic pump |
| 08/30/2006 | EP1694309A2 Artificial synapse chip |
| 08/30/2006 | EP1694308A1 Stable formulations of ace inhibitors and methods for preparation thereof |
| 08/30/2006 | EP1694307A2 Methods for the treatment of cancer |
| 08/30/2006 | EP1694306A2 Powder containing low-molecular dextran and method for producing the same |
| 08/30/2006 | EP1694305A2 Pharmaceutical compositions comprising lercanidipine |
| 08/30/2006 | EP1694304A2 Azithromycin multiparticulate dosage forms by liquid-based processes |
| 08/30/2006 | EP1694303A1 Taste masked pharmaceutical composition comprising ph sensitive polymer |
| 08/30/2006 | EP1694302A1 TASTE MASKED PHARMACEUTICAL COMPOSITIONS COMPRISING BITTER DRUG AND pH SENSITIVE POLYMER |
| 08/30/2006 | EP1694301A2 Methods and compositions for the production of monoclonal antibodies |
| 08/30/2006 | EP1694300A2 Dosing methods for beta-d-2',3'-dideoxy-2',3' -didehydro-5-fluorocytidine antiviral therapy |
| 08/30/2006 | EP1694299A2 Method for drug loading in liposomes |
| 08/30/2006 | EP1694298A2 Method for selecting cationic or anionic liposomes for treatment of a mucosa membrane, and kit comprising the same |
| 08/30/2006 | EP1694297A2 Controlled release analgesic suspensions |
| 08/30/2006 | EP1694296A1 Injectable composition |
| 08/30/2006 | EP1694295A1 Pharmaceutical oral dosage form comprising a non-steroidal anti-inflammatory drug, and having good palatability |
| 08/30/2006 | EP1694294A1 Pharmaceutical compositions with synchronized solubilizer release |
| 08/30/2006 | EP1694293A2 Composition and delivery system comprising multilayered microparticles |
| 08/30/2006 | EP1694292A2 Therapeutic foam comprising a sclerosing solution |
| 08/30/2006 | EP1694291A2 Endoparasiticidal agents for topical application |
| 08/30/2006 | EP1694286A2 Cosmetic and dermatological oxygen carrier system |
| 08/30/2006 | EP1694277A2 Methods of administering water-soluble prodrugs of propofol for extended sedation |
| 08/30/2006 | EP1694260A1 Methods and compositions for deterring abuse of opioid containing dosage forms |
| 08/30/2006 | EP1694242A1 Pharmaceutical formulations of camptothecins and process for making same |
| 08/30/2006 | EP1646328A4 Treatment of dependence withdrawal |
| 08/30/2006 | EP1606298B1 Direct compressible trehalose solids |
| 08/30/2006 | EP1482811B1 Process for the preparation of foods comprising a probiotic delivery system |
| 08/30/2006 | EP1399128B1 Composition for the treatment of diseases which affect animals' hooves |
| 08/30/2006 | EP1385519B1 Compounds for treating inflammatory diseases |
| 08/30/2006 | EP1349533B1 Propellant-gas-free spray preparations |
| 08/30/2006 | EP1294346B1 Structures and compositions increasing stability peroxide actives stability |
| 08/30/2006 | EP1276459B1 Cosmetic or dermatological cream composition, the preparation and the use thereof |
| 08/30/2006 | EP1272183B1 Methods and compositions useful in enhancing oxygen delivery to cells |
| 08/30/2006 | EP1250056B1 Composition for intestinal delivery |
| 08/30/2006 | EP1173487B1 Haze-free cellulose ether capsules and process for making |
| 08/30/2006 | EP1140262B1 Inhaler |
| 08/30/2006 | EP0946221B1 Use of taurolidine or taurultam for the prevention and the treatment of infections in delivery systems |
| 08/30/2006 | EP0909316B1 Glial cell line-derived neurotrophic factor receptor |
| 08/30/2006 | EP0755270B1 Microcapsules, method of making and their use |
| 08/30/2006 | EP0728200B1 Haemophilus transferrin receptor genes |
| 08/30/2006 | CN2810600Y Navel plaster for hepatic disease |
| 08/30/2006 | CN1826408A Large volume ex vivo electroporation method |
| 08/30/2006 | CN1826360A Thermosensitive polymers for therapeutic use and methods of preparation |
| 08/30/2006 | CN1826229A Dot-topography control of dissolution rate of bioactive agents |
| 08/30/2006 | CN1826228A Application of a bioactive agent to a delivery substrate |
| 08/30/2006 | CN1826170A Methods for fabrication, uses and compositions of small spherical particles of hgh prepared by controlled phase separation |
| 08/30/2006 | CN1826132A Formulation for a protein pharmaceutical without added human serum albumin (HSA) |
| 08/30/2006 | CN1826128A Turmeric-containing composition |
| 08/30/2006 | CN1826123A Acute inflammatory condition treatment |
| 08/30/2006 | CN1826117A Orally dissolving films |
| 08/30/2006 | CN1826113A Transdermaltherapeutic system containing a pramipexol active agent |
| 08/30/2006 | CN1826110A Semi-solid formulations for the oral administration of taxoids |
| 08/30/2006 | CN1826107A Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator |
| 08/30/2006 | CN1826103A Medical active agent patch optically less visible on skin |
| 08/30/2006 | CN1826102A Compositions comprising components coated with a liquid impermeable but gas permeable layer, use thereof for treating cutaneous and other exocrine gland diseases |
| 08/30/2006 | CN1826101A Pharmaceutical formulations |
| 08/30/2006 | CN1826100A 控释制剂 Controlled release formulations |
| 08/30/2006 | CN1826099A Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
| 08/30/2006 | CN1826098A Production of small particles |
| 08/30/2006 | CN1826097A Transnasal microemulsions containing diazepam |
| 08/30/2006 | CN1824322A Solubilization method of acyclovir in acyclovir injection liquid |
| 08/30/2006 | CN1824321A Yanhuning freeze dried powder for injection and its preparation method |
| 08/30/2006 | CN1824320A Medicinal composition containing calcium passage paralysor and B family vitamin and its use |
| 08/30/2006 | CN1824319A Hormone kind anticancer medicine slow release agent |
| 08/30/2006 | CN1824318A Slow release implantation agent for anticancer |
| 08/30/2006 | CN1824316A Liquid used for inhibiting bacterial infection and promoting skin growth |
| 08/30/2006 | CN1824314A Slow release agent containing hormone kind anti cancer medicine |